Department of Biochemistry, Molecular Neuroscience Center and Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, PR China.
Mol Brain. 2009 Sep 16;2:29. doi: 10.1186/1756-6606-2-29.
Parkinson's disease (PD) is the most common neurodegenerative movement disorder that affects about 1% of the population worldwide. Despite significant advances in the identification of genetic mutations and signaling pathways that are associated with the disease, the precise mechanisms implicated in the pathophysiology of the disease are not well understood. More importantly, treatments that are effective in reversing the progression of the disease is essentially lacking. Further investigation into the pathogenic mechanisms of PD thus presents a pressing concern for neuroscientists. Recently, deregulation of the autophagic pathway is observed in the brains of PD patients and in models of PD. In this review we summarize current literature on the emerging involvement of autophagy in PD, and the implication for future development of treatment against the disorder.
帕金森病(PD)是最常见的神经退行性运动障碍,影响全球约 1%的人口。尽管在鉴定与疾病相关的基因突变和信号通路方面取得了重大进展,但疾病病理生理学中涉及的确切机制仍不清楚。更重要的是,有效的治疗方法可以逆转疾病的进展,目前基本上还没有。因此,进一步研究 PD 的发病机制是神经科学家面临的紧迫问题。最近,在 PD 患者和 PD 模型的大脑中观察到自噬途径的失调。在这篇综述中,我们总结了自噬在 PD 中的新作用的现有文献,并对该疾病治疗方法的未来发展提出了启示。